HTRS Mid-Career Research Award

The window to submit Letters of Intent for the 2023 Mid-Career Research Award (MCRA) is closed.

Letters of Intent review is underway.

Invited Full Proposals are due Monday, December 12, 2022.

Please read the Request for Proposal (RFP) carefully, as key MCRA 2023 details including eligibility requirements have been refined for an improved program.  

The HTRS Mid-Career Research Award (MCRA) Program provides financial support for investigators pursuing clinical, translational, or basic science research projects in hemostasis and/or thrombosis. Applicants must be working in the United States or Canada for the duration of the proposed project.  Projects funded by this program run for two years from July 2023 to June 2025.

The goals of the MCRA Program are to:

1. Advance the science underlying the molecular basis or clinical management of hemostasis and thrombosis by supporting investigator-initiated research to ultimately improve the health and well-being of people living with blood disorders
2. Combat the shortage of skilled academic researchers in benign hematology by supporting investigators in the U.S. and Canada at a critical juncture in their academic research careers. 
3. Provide financial support for talented investigators to enable them to transition from mentored research to full research independence by filling the gap between career development awards and R01 level funding.

General Eligibility Requirements:

Eligible applicants for the MCRA must demonstrate a commitment to academic research careers in non-malignant hematology and fulfill the following requirements:    

1. Have an MD, DO, PhD, MD/PhD, or equivalent doctoral degree
2. Hold a faculty position at an institution in the U.S. or Canada 
3. Have had significant career development award funding
4. Be working toward, and eligible to receive, a first R01 or equivalent in the U.S. or Canada
5. Be able to demonstrate a clear path by which the MCRA will support submission of an R01 or equivalent in the U.S. or Canada

If applicants are also eligible to apply for the Mentored Research Award (MRA), HTRS strongly encourages application to the MRA before applying for the MCRA.
 
How to Apply

• Submit applications on the HTRS Grant Application site
• Applicants who have not already applied for an HTRS award on the grant application site should click on "Register" and create a new account with an email and password
• The site allows you to save your work and return to it later

Questions should be directed to Jennifer Ziegler in the HTRS office at [email protected].
 

Lacramioara Ivanciu, PhD - Children's Hospital of Philadelphia

The 2021 MCRA was supported by a grant from HTRS.

Bryce A. Kerlin, MD
The Research Institute at Nationwide Children's Hospital

The 2020 MCRA was supported by a grant from Genentech, a member of the Roche Group.

Jill M. Johnson
Bloodworks Northwest Research Institute

The 2019 MCRA was supported by an educational grant from Genentech.

Shannon L. Meeks, MD
Emory University

The 2017 MCRA was supported by the Hemostasis and Thrombosis Research Society.